“…Furthermore, binding of Pfk to intracellular proteins such as calmodulin (Marinho-Carvalho et al, 2006), actin (Liou & Anderson, 1980), microtubules (Vé rtessy et al, 1997) and caveolin 1 (Vallejo & Hardin, 2005) modulates the activity, oligomeric equilibrium and localization of Pfk within the cell. Moreover, the equilibrium between monomer, dimers, tetramers and higher oligomers affects Pfk activity (Trujillo & Deal, 1977;Luther et al, 1983). Mutations in the muscle Pfk gene can lead to type VII glycogen storage disease (Tarui disease; Toscano & Musumeci, 2007).…”